| 释义 |
Rituxan 英rɪt'jʊksən美rɪt'jʊksən COCA³¹⁵¹¹¹⁺⁴
基本例句
B细胞单克隆抗体
More data are needed to determine the safety of more than one course of Rituxan and long term safety of use of Rituxan in patients with WG and MPA.
需要更多的数据才能确定 WG和 MPA患者接受1个以上疗程 Rituxan治疗的安全性以及长期安全性。 dxy
Retreatment with Rituxan was not formally evaluated; therefore, the safety and efficacy of retreatment with subsequent courses of Rituxan has not been established.
使用 Rituxan的再治疗还未进行过正式评价，因此 Rituxan后续进行再治疗的安全性和有效性还未能证实。 biozx
The drug co- developers have already begun a clinical trial of Rituxan in a more severe form of the disease, primary progressive multiple sclerosis.
这种药物的联合开发者们已经开始在更加严重的多发性硬化患者里开展了临床试验，主要是进行性的多发性硬化病人。 dxy
Rituxan is currently approved as a treatment for non- Hodgkin's lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.
Rituxan现在已经被批准用于非霍奇金淋巴瘤、慢性淋巴细胞白血病和风湿性关节炎的治疗。 yeeyan
Rituxan is not recommended for use in patients with severe, active infections.
Rituxan不被推荐用于严重、活动性感染的患者。 biozx
“ We like Rituxan, and we think those trials are going to be successful, ” Flynn said.
福林说，我们喜欢 Rituxan，我们认为试验将会成功。 dxy |